Combined oxidative phosphorylation deficiency type 5 (Q95528): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A deficiência combinada de fosforilação oxidativa tipo 5 é caracterizada por hipotonia severa, academia láctica e hiperamonemia congênita. Foi descrito em três recém-nascidos de pais consanguíneos. O exame de ultrassom durante a 36ª semana de gravidez revelou edema generalizado. A cardiomiopatia hipertrófica e a tubulopatia desenvolveram-se na primeira semana de vida e os bebês morreram no primeiro mês. As atividades das enzimas da cadeia respiratória mitocondrial foram reduzidas na musculatura dos pacientes. Mutações foram identificadas no gene MRPS22, que codifica uma proteína ribossômica mitocondrial.
description / endescription / en
 
Combined oxidative phosphorylation deficiency type 5 is characterised by severe hypotonia, lactic academia and congenital hyperammonaemia. It has been described in three newborns born to consanguineous parents. Ultrasound examination during the 36th week of pregnancy revealed generalised oedema. Hypertrophic cardiomyopathy and tubulopathy developed within the first week of life and the infants died within the first month. The activities of enzymes in the mitochondrial respiratory chain were reduced in the muscles of the patients. Mutations were identified in the MRPS22 gene, encoding a mitochondrial ribosomal protein.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/373222828 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_373222828
Property / CURIE: CID11:ID_373222828 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_373222828
Property / Canary Token: dki-india-ID_373222828 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 11:19, 16 August 2026

Combined oxidative phosphorylation deficiency type 5 is characterised by severe hypotonia, lactic academia and congenital hyperammonaemia. It has been described in three newborns born to consanguineous parents. Ultrasound examination during the 36th week of pregnancy revealed generalised oedema. Hypertrophic cardiomyopathy and tubulopathy developed within the first week of life and the infants died within the first month. The activities of enzymes in the mitochondrial respiratory chain were reduced in the muscles of the patients. Mutations were identified in the MRPS22 gene, encoding a mitochondrial ribosomal protein.
Language Label Description Also known as
default for all languages
ID_373222828
    English
    Combined oxidative phosphorylation deficiency type 5
    Combined oxidative phosphorylation deficiency type 5 is characterised by severe hypotonia, lactic academia and congenital hyperammonaemia. It has been described in three newborns born to consanguineous parents. Ultrasound examination during the 36th week of pregnancy revealed generalised oedema. Hypertrophic cardiomyopathy and tubulopathy developed within the first week of life and the infants died within the first month. The activities of enzymes in the mitochondrial respiratory chain were reduced in the muscles of the patients. Mutations were identified in the MRPS22 gene, encoding a mitochondrial ribosomal protein.

      Statements

      CID11:ID_373222828
      0 references
      dki-india-ID_373222828
      0 references
      Concluído
      0 references
      15 August 2026
      0 references